Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114998 · ClinicalTrials.gov registry record
CV Disease in Adolescents With Type 2 Diabetes
A clinical trial of Obesity and Cardiovascular Diseases, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT00114998: Completed study of Obesity and Cardiovascular Diseases, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT00114998 is a study of Obesity and Cardiovascular Diseases that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 750 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00114998, a study of Obesity and Cardiovascular Diseases, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
To study cardiac and vascular structure and function in a population of adolescents with type 2 diabetes mellitus (T2DM) compared to a similar group with obesity alone and a similar non-obese group.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-06 |
What the finished NCT00114998 record still lists
NCT00114998 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT00114998 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00114998 about?
NCT00114998 is a clinical study titled "CV Disease in Adolescents With Type 2 Diabetes". To study cardiac and vascular structure and function in a population of adolescents with type 2 diabetes mellitus (T2DM) compared to a similar group with obesity alone and a similar non-obese group.
What is the current status of trial NCT00114998?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2005-06. Estimated completion is 2011-06.
What conditions does trial NCT00114998 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Diabetes Mellitus, Heart Diseases.
Who is sponsoring clinical trial NCT00114998?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114998 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00114998's enrollment target sits among peer trials
750 99th of 1053 higher than 954 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia